Set StockTrendNews.com as your Homepage! - Click Here Home     About Us     Subscribe     Contact
 
StockTrendNews (STN) Exclusive: Transition Therapeutics Inc
Enter Symbol or Keywords
x
Twelve Months Cash Flow from Operations Turns Negative for Transition Therapeutics   Stock Quote: (NGM:TTHI)
11/20/2009  
4.00 +0.01 +0.25% 7,400
Twelve Months Cash Flow from Operations Turns Negative for Transition Therapeutics  
Last Price Change % Chg Volume
New York, NY, November 20, 2009-CFFO-NEWS reports that Cash Flow from Operations (CFFO) for Transition Therapeutics, Inc. (NASDAQ:TTHI) for its twelve months ended September 30, 2009 was a negative $( ... read full story  
Website Address: www.transitiontherapeutics.com
Industry: Bio-Pharma & Therapeutics
Most Recent STN Exclusives
x
09/08/2010
EBITDA Increases 6.7% for Lowe's Companies
09/08/2010
Fourteen Year Low in EBITDA for Positron
09/08/2010
Revenue for Tiffany Increases by 11.06% even though Revenue for Jewelry and Watches Industry Decreases by 9.86% over Latest 12 Months
09/08/2010
T12-NEWS reports that the Brown-Forman's Revenue for its 12 month ended July 31, 2010 Increased by 1.21%
09/08/2010
Free Cash Flow Decreases 24% for H&R Block
09/08/2010
Harris' EBITDA Turns Positive for its Fourth Quarter
09/08/2010
VeriFone Holdings' OPS Ranking of "1" Reiterated by StockDiagnostics.com
09/08/2010
Toronto-Dominion Bank's OPS Ranking of "1" Reiterated by StockDiagnostics.com
09/08/2010
OPS Ranking of "1" Reiteration for Brocade Communications Systems
09/08/2010
SAIC's OPS Ranking of "1" Reiterated by StockDiagnostics.com
Interactive Chart: TTHI
x
More STN Exclusives for: TTHI
x
05/26/2010
EBITDA for Transition Therapeutics Reaches Four Year High
05/24/2010
Transition Therapeutics' OPS Ranking of "8" Reiterated by StockDiagnostics.com
05/24/2010
Eight Year Low in Free Cash Flow for Transition Therapeutics
... more TTHI exclusives
Other News Sources: TTHI
x
08/17/2010
Zacks Analyst Blog Highlights: Elan, Transition Therapeutics, Pfizer, Novartis AG, Johnson & Johnson and Forest Laboratories
08/09/2010
Elan And Transition Therapeutics Announce Topline Summary Results Of Phase 2 Study and Plans for Phase 3 for ELND005 (Scyllo-inositol )
06/30/2010
Transition Therapeutics Announces Initiation of a Phase I Clinical Study of TT-301
... more TTHI news from other sources
Daily Market Updates
x
09/08/2010
Markets End Off Highs Following Slower Growth in Beige Book and Obama Rant
The market ended off their highs of the session the session following the Fed's Beige Book release and President Obama's proposal for new stimulus programs and rant against Republicans. The Fed noted that the economic expansion in the U.S. is continu ... read full story

30 Day Free Trial - MarketWatch Retirement Weekly

Free 30 Day Trial -MarketWatch Hulbert Interactive

Visit Tradesight



Sponsored Links
Attend a Free Webinar on How to Trade Stocks
InvestView.com
Increase Your Stock Market Performance by Using the News Management Interface that the Pros Use
Knobias.com

 
 
 
x


 
x
     
 
©2010 StockTrendNews.com
Disclaimer Terms of Sales Privacy About Us